B17 IN VITRO AND IN VIVO CHARACTERIZATION OF THE VASOPRESSIN RECEPTOR ANTAGONIST SSR149415
Cliona MacSweeney, Hugh Marston, Lesa Watson, Susan Napier, Frédéric Martin, Nathan P. Ward(Moffitt Cancer Center), Jillian G. Baker(Nottingham University Hospitals NHS Trust), Mark Craighead, T. Idle, Fiona Thomson(University of Glasgow), Alison M. Bratt, Rachel Milne, Kim Anderson, Greg Goodwin
Cited by 0
Related Papers
Structure of a β1-adrenergic G-protein-coupled receptor
|Nature|2008|1.3k
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
|Nature|2011|623
The selectivity of β‐adrenoceptor agonists at human β<sub>1</sub>‐, β<sub>2</sub>‐ and β<sub>3</sub>‐adrenoceptors
|British Journal of Pharmacology|2010|586
The selectivity of <i>β</i>‐adrenoceptor antagonists at the human <i>β</i>1, <i>β</i>2 and <i>β</i>3 adrenoceptors
|British Journal of Pharmacology|2005|535
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390